Detection method and device suitable for multiple mutation types of multiple disease-related genes, computer equipment, storage medium and computer program product

Through the third generation of long-read and long-sequencing technology and targeted capture methods, multiple variant types of genes related to multiple single-gene disease are simultaneously detected within the same reaction system, and the limited detection range and false positive false in the existing technology are solved. Negative problems improve the accuracy and accuracy of the detection.

CN119068981APending Publication Date: 2024-12-03SUZHOU BASECARE MEDICAL DEVICE CO LTD
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411042845.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing chromosomal single gene mutation detection methods have problems such as single detection of diseases, low flux, low sensitivity and specificity, and limited detection range. Especially when detecting highly homologous sequences, short tandem repeats and structural mutations, falsehood is prone to occur. Negative or false positive, and multiple variant types cannot be detected simultaneously.

Method used

The third-generation long read and long sequencing technology combined with targeted capture method is used to obtain the long fragment DNA sequence of the target gene. By comparing and analyzing the mutation information of conventional and unconventional genes, the simultaneous detection of point mutations and missing duplications within the same reaction system are achieved. , gene fusion, large segment gene conversion, short tandem repeat mutations and gene inversion and other variant types.

Benefits of technology

Improve the sensitivity and specificity of the detection, can accurately identify multiple variant types of genes related to multiple single-gene disease, solve the problem of homologous gene sequence interference, clarify the cis and trans situations of the variant, and improve the Copy number variation recognition accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119068981A_ABST
    Figure CN119068981A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of gene sequencing, in particular to a detection method suitable for multiple mutation types of genes related to multiple diseases, and the method comprises the following steps: comparing a sequence read of third-generation long-read long sequencing with a reference genome, comparing a part of the sequence read to a conventional gene region to obtain a first comparison result, and comparing the first comparison result with a second comparison result to obtain a second comparison result; carrying out first variation analysis according to the first comparison result, outputting a first analysis result, and carrying out haplotype typing on the unconventional gene to obtain a difference base sequence of the unconventional gene and a highly homologous sequence of the unconventional gene, and comparing the differential base sequence with the residual sequence reading to obtain a second comparison result, performing second variation analysis according to the second comparison result, and outputting a second analysis result. According to the application, multiple variation types of multiple monogenic disease genes can be screened at the same time, and interference of highly homologous genes can be eliminated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of gene detection technology, and in particular to a method, device, computer equipment, storage medium and computer program product for detecting a single gene mutation of a chromosome. Background Art

[0002] Single gene genetic diseases refer to genetic diseases controlled by a pair of alleles, such as hemophilia, spinal muscular atrophy, thalassemia, congenital adrenal hyperplasia, pseudohypertrophic muscular dystrophy, etc. There are many types of single gene genetic diseases, most of which are lethal, disabling or teratogenic, and lack effective treatment methods or are expensive. Single gene genetic diseases not only pose a serious threat to the health and quality of life of individual patients, but also bring heavy economic and psychological burdens to families, and pose challenges to the medical and social security systems of society. Therefore, raising awareness of single gene genetic diseases, strengthening genetic counseling and screening, and promoting the development of related medical technologies are crucial to reducing the impact of these diseases.

[0003] Traditional detection methods for single chromosomal gene mutations have defects such as single disease detection, low throughput, low sensitivity and specificity, and limited detection range. Modern sequencing technology (Next-Generation Sequencing, NGS) has become an important tool widely used in screening gene mutation types due to its many advantages.

[0004] Although NGS technology is very useful in many cases, there may be some special cases that require additional analytical methods or technologies to supplement its detection range. For example, when detecting mutation types of genetic diseases of certain special single genes, it may be limited by the short read length of NGS and cannot detect complex variations on the genome, including the identification and analysis of highly homologous sequences, short tandem repeats (STRs), and structural variation sequences. For highly homologous sequences or the presence of pseudogenes, due to the influence of the short read length of NGS, it is impossible to determine whether the sequence carrying the mutant base is from the functional gene or its homologous sequence. Therefore, in the test results for the above genes, false negatives or false positives often occur, which need to be verified and supplemented by other detection technologies. In addition, for a gene mutation with two or more mutations, it is particularly important to determine the cis and trans conditions of the mutation in order to assess the pathogenicity of the individual. However, NGS detection technology is limited by the read length and cannot determine the above situation. For the verification of such cases, it is necessary to design PCR amplification primers for verification, which consumes a lot of manpower and cannot achieve high-throughput quantification.

[0005] In view of the defect that the detection methods available on the market cannot simultaneously detect point mutations, deletion duplications, gene fusions, large-segment gene conversions, short tandem repeat mutations, inversions and other types of mutations in the same experimental system, it is necessary to further improve the NGS technology. Summary of the invention

[0006] Based on this, one or more embodiments of the present application provide a method, apparatus, computer device, storage medium and computer storage medium product for detecting multiple mutation types of genes related to multiple diseases, which can screen multiple variation types of genes related to multiple single-gene genetic diseases, and can simultaneously detect point mutations, deletions and duplications, gene fusions, large-segment gene conversions, short tandem repeat mutations, gene inversions and other variations in the same reaction system.

[0007] The technical solution of this application includes the following contents:

[0008] A method for detecting multiple mutation types of multiple disease-related genes, comprising the following steps:

[0009] S100: Obtain genomic DNA of the sample, obtain the long-fragment DNA sequence of the target gene in the genomic DNA by a targeted capture method, and perform third-generation long-read sequencing;

[0010] S200: comparing the sequence reads of the third-generation long-read sequencing with the reference genome, comparing a portion of the sequence reads to the conventional gene region to obtain a first comparison result, performing a first variation analysis based on the first comparison result, and outputting a first analysis result; and performing haplotype typing on the unconventional gene to obtain a differential base sequence between the unconventional gene and its highly homologous sequence, comparing the differential base sequence with the remaining portion of the sequence reads to obtain a second comparison result, performing a second variation analysis based on the second comparison result, and outputting a second analysis result;

[0011] S300: Summarize the first analysis result and the second analysis result, and output a gene mutation analysis result;

[0012] Among them, the conventional gene refers to a gene without a highly homologous sequence, the unconventional gene refers to a gene with a highly homologous sequence, and the gene with a highly homologous sequence means that the gene has a homologous sequence with a similar sequence structure within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%;

[0013] The first analysis result and the second analysis result each independently include at least one of the following gene mutation results: single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement.

[0014] In one embodiment, the method for obtaining the long-fragment DNA sequence of the target gene in the genomic DNA includes at least one of probe hybridization capture, PCR amplification and targeted gene editing.

[0015] In one embodiment, the sequencing platform of the third generation sequencing includes at least one of a single molecule real-time sequencing technology platform and a single molecule nanopore sequencing technology platform.

[0016] In one embodiment, the long DNA sequence satisfies at least one of the following conditions:

[0017] (1) Average length > 5 kb;

[0018] (2) Length ranges from 500bp to 300kb.

[0019] In one embodiment, performing a first variation analysis according to the first comparison result includes:

[0020] Analyzing first variation information of the conventional gene according to the first comparison result, the first variation information including single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat and structural variation;

[0021] Furthermore, the structural variation includes copy number variation.

[0022] In one embodiment, performing a first variation analysis according to the first comparison result and outputting a first analysis result further includes:

[0023] The conventional gene is subjected to haplotype typing according to the information of the heterozygous SNP in the first comparison result.

[0024] In one embodiment, performing a second variation analysis according to the second comparison result includes:

[0025] analyzing second variation information of the unconventional gene according to the second comparison result, wherein the second variation information includes at least one of single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement;

[0026] Furthermore, the structural variation includes at least one of copy number variation, gene fusion, and large-segment gene conversion and inversion;

[0027] Furthermore, the complex genome rearrangement refers to the occurrence of multiple types of structural variations within the same gene region.

[0028] In one embodiment, haplotype typing is performed on the unconventional gene to obtain a differential base sequence between the unconventional gene and a highly homologous sequence therein, the differential base sequence is compared with the remaining sequence read to obtain a second comparison result, a second variation analysis is performed based on the second comparison result, and a second analysis result is output, including:

[0029] S221: Record the unconventional genes as a set G, including genes G1 to GN, and establish a reference genome set R for each gene, including reference genomes R1 to RN, and establish a corresponding reference genome index;

[0030] S222: For gene G1 and its reference genome R1, extract the sequencing fragment sequences aligned to G1 and its highly homologous sequence regions according to the sequence alignment results to form set S1;

[0031] S223: Align the sequencing fragment sequences in set S1 to the reference genome R1;

[0032] S224: extract the reference genome R1 of gene G1 and the reference genome set P of highly homologous sequences, including P1 to PN, and compare R1 with the sequences in the set P to determine the position set B of the differential base sequences, including B1 to BN, wherein for each position Bi, record its corresponding base information set BNi and reference genome number set C, and complete the recording of all base information sets in the set B and the corresponding reference genome numbers;

[0033] S225: According to the results of steps S223 and S224, the sequences aligned to the reference genome R1 are numbered and marked, and all positions of set B are traversed;

[0034] S226: Haplotype marking of the aligned sequences. If all positions of set B are marked as R1, then it is recorded as R1 haplotype; if some positions are marked as R1 and some are marked as P1 to PN, then it is recorded as other haplotype type set O;

[0035] S227: Perform cluster analysis on sequences of all haplotype types, record the number sets of different haplotypes and the corresponding average number of sequences, where:

[0036] For the haplotype set O, if there is one or multiple discontinuous positions Bi marked as non-R1, the haplotype is considered to be R1, indicating the presence of point mutations or insertions and deletions. If there are multiple consecutive positions Bi marked as non-R1, it is considered that the haplotype has undergone gene fusion or structural variation.

[0037] For the R1 haplotype, when the number of the R1 haplotype number set is greater than 2, it is considered that the gene G1 has a copy number duplication; when the number of the R1 haplotype number set is less than or equal to 1, it is considered that the gene G1 has a copy number deletion; when the value of the average sequence number DN corresponding to the R1 haplotype number is 1.5 to 2.5 times the value of the other number D, it is considered that there are two identical copies of the haplotype number, and the copy number variation determination result is updated accordingly;

[0038] S228: For genes G2 to GN, perform the second variation analysis in the same manner as S222 to S227.

[0039] A detection device, comprising:

[0040] The alignment module is used to align the sequence reads of the third-generation long-read sequencing with the reference genome;

[0041] An analysis module is used to compare the sequence reads of the third-generation long-read sequencing with the reference genome, align a portion of the sequence reads to the conventional gene region to obtain a first comparison result, perform a first variation analysis based on the first comparison result, output the first analysis result, perform haplotype typing on the unconventional gene, obtain a differential base sequence between the unconventional gene and its highly homologous sequence, compare the differential base sequence with the remaining portion of the sequence reads to obtain a second comparison result, perform a second variation analysis based on the second comparison result, and output the second analysis result;

[0042] Output module: used to summarize the first analysis result and the second analysis result, and output the gene mutation analysis result;

[0043] Among them, the conventional gene refers to a gene without a highly homologous sequence, the unconventional gene refers to a gene with a highly homologous sequence, and the gene with a highly homologous sequence means that the gene has a homologous sequence with a similar sequence structure within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%;

[0044] The first analysis result and the second analysis result each independently include at least one of the following gene mutation results: single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement.

[0045] A computer device comprises a memory and a processor, wherein the memory stores a computer program, and the processor implements the steps of the detection method described above when executing the computer program.

[0046] A computer-readable storage medium stores a computer program, which implements the steps of the detection method described above when executed by a processor.

[0047] A computer program product comprises a computer program, which implements the steps of the detection method described above when executed by a processor.

[0048] The detection method of the present application can be used to screen genes related to hereditary diseases with single gene mutations. The method is a targeted capture method based on high-precision, long-read third-generation gene sequencing technology, which can simultaneously screen multiple types of variations of multiple single gene disease genes, and can simultaneously detect single nucleotide polymorphisms, small-scale insertions and deletions, short tandem repeats, structural variations, complex genome rearrangements and other mutation types in the same reaction system. Structural variations including copy number variations, gene fusions, large-segment gene conversions, short tandem repeat mutations and gene inversions can all be identified, and complex genome rearrangements of multiple structural variations occurring in the same gene region can be identified.

[0049] In the detection method of the present application, in terms of analysis, through the assembly of long-fragment genomes, the haplotype of pathogenic variants can be constructed, and the cis and trans conditions of the variants can be clarified. This can solve the analysis of variants in the presence of interference from homologous gene sequences, including accurate identification of variants such as mutations, deletions and duplications, gene fusions, large-segment gene conversions, and gene inversions. At the same time, the copy number is determined based on the haplotype, solving the problem of accuracy in identifying copy number variants in third-generation sequencing. BRIEF DESCRIPTION OF THE DRAWINGS

[0050] In order to more clearly illustrate the specific implementation methods of the present application or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0051] Figure 1 This is a flowchart of a method for detecting a single gene mutation in a chromosome according to an embodiment of the present application.

[0052] Figure 2 This is a structural block diagram of a device for detecting a single gene mutation of a chromosome according to an embodiment of the present application.

[0053] Figure 3 This is the IGV spectrum of sample YYR of Example 1 of Example 1 of the present application.

[0054] Figure 4 This is the IGV spectrum of the sample LSQ of Example 1 of the present application.

[0055] Figure 5 This is the IGV spectrum of sample YMX of Example 1 of the present application.

[0056] Figure 6 This is the IGV spectrum of sample SYK of Example 1 of the present application.

[0057] Figure 7 This is the IGV spectrum of sample ZXR in Example 1 of the present application.

[0058] Figure 8 It is the IGV spectrum of sample GAA_test7 of Example 1 of the present application.

[0059] Fig. 9 This is the IGV spectrum of sample TQQ of Example 1 of the present application.

[0060] Fig.10 This is the IGV spectrum of sample LH in Example 1 of the present application.

[0061] Fig.11 It is the IGV spectrum of sample FMR1_test2 of Example 1 of the present application.

[0062] Fig.12 This is the MLPA spectrum of sample YYR of Comparative Example 1 of the present application.

[0063] Fig.13 This is the PCR amplification result of the sample LSQ of Comparative Example 1 of the present application. DETAILED DESCRIPTION

[0064] The present application will be further described below in conjunction with the embodiments and examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. In addition, it should be understood that after reading the content taught in the present application, those skilled in the art may make various changes or modifications to the present application, and these equivalent forms also fall within the protection scope of the claims attached to the present application.

[0065] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit this application.

[0066] the term

[0067] Unless otherwise specified or incompatible herewith, the terms and phrases used herein shall have the following meanings:

[0068] The terms "and / or", "or / and", and "and / or" used in this article include any one of two or more related listed items, and also include any and all combinations of related listed items, and the arbitrary and all combinations include any two related listed items, any more related listed items, or a combination of all related listed items. It should be noted that when at least three items are connected by at least two conjunctions selected from "and / or", "or / and", and "and / or", it should be understood that in this application, the technical solution undoubtedly includes technical solutions that are all connected by "logical and", and undoubtedly includes technical solutions that are all connected by "logical or". For example, "A and / or B" includes three parallel solutions of A, B and A+B. For example, the technical solution of "A, and / or, B, and / or, C, and / or, D" includes any one of A, B, C, and D (that is, the technical solution that is all connected by "logical OR"), and also includes any and all combinations of A, B, C, and D, that is, the combination of any two or any three of A, B, C, and D, and also includes the combination of four of A, B, C, and D (that is, the technical solution that is all connected by "logical AND").

[0069] Herein, "preferred", "preferable", "better", etc. are only used to describe implementation methods or examples with better effects. It should be understood that they do not constitute limitations on the scope of protection of this application.

[0070] In the present application, "further", "further", "particularly" and the like are used for descriptive purposes to indicate differences in content, but should not be construed as limiting the scope of protection of the present application.

[0071] In the present application, the technical features described in an open manner include closed technical solutions composed of the listed features, and also include open technical solutions containing the listed features.

[0072] In the present application, when it comes to numerical intervals (i.e., numerical ranges), unless otherwise specified, the optional numerical distribution is considered continuous within the above numerical interval, and includes the two numerical endpoints (i.e., the minimum and maximum values) of the numerical range, and each numerical value between the two numerical endpoints. Unless otherwise specified, when the numerical interval only refers to integers within the numerical interval, it includes the two endpoint integers of the numerical range, and each integer between the two endpoints. In addition, when multiple ranges are provided to describe features or characteristics, these ranges can be combined. In other words, unless otherwise specified, the ranges disclosed herein should be understood to include any and all subranges included therein.

[0073] In the present application, weight may be μg, mg, g, kg or other mass units known in the chemical industry.

[0074] In order to overcome the recognition defects caused by the limitation of NGS read length, this application has developed a targeted capture method based on high-precision long-read third-generation gene sequencing technology, which can simultaneously screen multiple types of variations of multiple single-gene disease genes, and can realize the simultaneous detection of single nucleotide polymorphisms (SNPs), small-scale insertions and deletions (INDELs), short tandem repeats (STRs), structural variations (SVs) and complex genomic rearrangements (CGRs) in the same reaction system.

[0075] Single Nucleic Polymorphism (SNP) includes single base pair substitutions, insertions and deletions. Small-scale Insertions and Deletions (INDEL) usually refer to insertions or deletions that affect several to dozens of base pairs. Short Tandem Repeat (STR) includes short tandem repeat mutations, which involve changes in the number of repeat units in tandem repeat sequences. Structural Variants (SV) include chromosome copy number variations (duplications and deletions, which are greater than 50 base pairs), gene fusions, large-segment gene conversions and inversions. These variations involve the rearrangement or change of direction of larger fragments of DNA sequences. Complex Genome Rearrangements (CGR) occur when a variation event contains multiple types of structural changes, such as simultaneous insertions, deletions and inversions.

[0076] refer to Figure 1 The method for detecting a single gene mutation in a chromosome according to an embodiment of the present application comprises the following steps:

[0077] S100: Obtain genomic DNA of the sample, obtain the long-fragment DNA sequence of the target gene in the genomic DNA through targeted capture method, and perform third-generation long-read sequencing;

[0078] S200: comparing the sequence reads of the third-generation long-read sequencing with the reference genome, comparing a portion of the sequence reads to the conventional gene region to obtain a first comparison result, performing a first variation analysis based on the first comparison result, outputting a first analysis result, performing haplotype typing on the unconventional gene, obtaining a differential base sequence between the unconventional gene and its highly homologous sequence, comparing the differential base sequence with the remaining portion of the sequence reads to obtain a second comparison result, performing a second variation analysis based on the second comparison result, and outputting a second analysis result;

[0079] S300: Summarize the first analysis result and the second analysis result, and output the gene mutation analysis result;

[0080] Among them, conventional genes refer to genes without highly homologous sequences, unconventional genes refer to genes with highly homologous sequences, and genes with highly homologous sequences refer to genes with homologous sequences with similar sequence structures within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%;

[0081] The first analysis result and the second analysis result each independently include at least one of the following gene mutation results: single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement.

[0082] The following is a further description of steps S100 to S300:

[0083] Step S100: Obtain genomic DNA of a sample, obtain long-fragment DNA sequences of target genes in the genomic DNA by a targeted capture method, and perform third-generation long-read sequencing.

[0084] Optionally, the method for obtaining a long DNA sequence of a target gene in genomic DNA includes at least one of probe hybridization capture, PCR amplification, and targeted gene editing. It can be understood by those skilled in the art that probe hybridization capture includes hybridizing a specific probe synthesized on a solid or liquid chip with a target region to enrich the target DNA fragment; multiplex PCR amplification includes designing multiple specific primers for the target region and performing PCR amplification to enrich the target DNA fragment, and targeted editing includes accurately capturing the target gene based on a gene editing system combined with a specific sgRNA.

[0085] Optionally, the sequencing platform of the third-generation sequencing includes at least one of a single-molecule real-time sequencing technology platform and a single-molecule nanopore sequencing technology platform.

[0086] Optionally, the obtained long-fragment DNA sequence satisfies at least one of the following conditions:

[0087] (1) Average length > 5 kb;

[0088] (2) Length ranges from 500bp to 300kb.

[0089] In one embodiment, genomic DNA of a sample is obtained, a long-fragment DNA sequence of a target gene in the genomic DNA is obtained by a targeted capture method, and third-generation long-read sequencing is performed, including:

[0090] S110 obtains genomic DNA of the sample.

[0091] Optionally, the sample source may be peripheral blood or the like.

[0092] Optionally, the genomic DNA of the sample can be obtained by extracting DNA using a magnetic bead method, column chromatography, or alkaline lysis method.

[0093] S120 Pre-capture library construction, this step is used to perform appropriate cleavage and adapter processing on the nucleic acid obtained in S110.

[0094] Optionally, the pre-capture library construction method can be a Tn5 transposase library construction method that can complete DNA fragmentation, end repair, A tailing, adapter ligation, etc. in one step. It can also be a physical method to fragment the DNA to a suitable size, and then complete the pre-capture library construction through enzymatic reactions such as end repair, A tailing, adapter ligation, etc.

[0095] S130: screening of pre-capture library fragments, which is used to remove nucleic acid fragments that do not meet the conditions in the pre-capture library obtained in S120 as much as possible, specifically, to remove nucleic acids with a fragment length of less than 5 kb;

[0096] S140: Target region capture. This step is used to label the nucleic acid fragments in the pre-capture library obtained in S130 to obtain a post-capture library.

[0097] Optionally, amplification is performed prior to labeling with biotin.

[0098] Optionally, the amplification reaction system includes: the nucleic acid fragment obtained in S130, a specific primer N and a 2×PCR mixed solution.

[0099] Optionally, the reaction conditions for amplification are as follows:

[0100]

[0101] Optionally, in S140, the nucleic acid fragments obtained in S130, the probe labeled with biotin and a buffer are mixed, hybridized and incubated, and after hybridization and incubation, the nucleic acid fragments labeled with biotin are captured.

[0102] Optionally, the reaction system of hybridization incubation includes: the nucleic acid fragments obtained in S130, a buffer, a blocking solution and nuclease-free water.

[0103] Optionally, the reaction conditions for hybridization incubation are as follows:

[0104] Temperature Time

[0105] 79℃~81℃, 4min~6min;

[0106] 49℃~51℃, 12h~18h.

[0107] Optionally, streptavidin affinity magnetic beads are used to capture the biotin-labeled nucleic acid fragments.

[0108] S150 third-generation library construction: This step is used to perform damage repair, end repair, third-generation sequencing adapter ligation, and magnetic bead purification on the nucleic acid fragments in the captured library obtained in S140 to complete the third-generation sequencing library construction.

[0109] S160 is used for sequencing. This step is used to perform third-generation sequencing on the third-generation library constructed by S150.

[0110] Preferably, sequencing is performed on the machine according to the operating procedures of a high-precision and long-length third-generation sequencing platform to obtain the third-generation sequencing data to be analyzed.

[0111] Step S200: Outputting gene mutation analysis results based on the comparison results of the sequence reads of the third-generation long-read sequencing in S100 with the reference genome.

[0112] In S200, the sequence reads of the third-generation long-read sequencing are compared with the reference genome, and a part of the sequence reads can be successfully matched to the conventional gene region, thereby obtaining a first comparison result. The mutation of the conventional gene is directly analyzed according to the first comparison result, and the remaining part cannot be successfully matched to the sequence reads of the conventional gene region. In this case, corresponding to the unconventional gene region, the unconventional gene is firstly haplotyped, and then the difference base sequence between the unconventional gene and its highly homologous sequence is obtained according to the result of haplotype typing. The difference base sequence is compared with the sequence reads of the remaining part in the above text to obtain a second comparison result, and the mutation of the unconventional gene is analyzed according to the second comparison result. In this way, the detection of multiple mutation types of multiple genes can be realized simultaneously in one system, taking into account the detection of conventional genes and unconventional genes as well as some mutation types that are missed or misdetected due to the accuracy of the third-generation sequencing.

[0113] Herein, conventional genes refer to genes without highly homologous sequences, and unconventional genes refer to genes with highly homologous sequences.

[0114] Herein, a gene with highly homologous sequences means that the gene has homologous sequences with similar sequence structures within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%.

[0115] Performing a first variation analysis according to the first comparison result includes:

[0116] In some of the embodiments, first variation information of conventional genes is analyzed according to the first comparison result, and the first variation information includes single nucleotide polymorphisms, small-scale insertions and deletions, short tandem repeats, and structural variations;

[0117] Furthermore, structural variation includes copy number variation.

[0118] In some of the embodiments, performing a first variation analysis based on the first comparison result and outputting the first analysis result also includes performing haplotype typing on conventional genes based on information on heterozygous SNPs in the first comparison result, thereby detecting a wider range of genomic structural variations.

[0119] In some embodiments, performing a second variation analysis based on the second comparison results includes:

[0120] analyzing second variation information of the unconventional gene according to the second comparison result, the second variation information comprising at least one of single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement;

[0121] Further, the structural variation includes at least one of copy number variation, gene fusion, and large segment gene conversion and inversion;

[0122] Furthermore, complex genomic rearrangements refer to situations in which multiple types of structural variations occur within the same gene region.

[0123] In some embodiments, haplotype typing is performed on the unconventional gene to obtain a differential base sequence between the unconventional gene and its highly homologous sequence, the differential base sequence is compared with the remaining sequence reads to obtain a second comparison result, a second variation analysis is performed based on the second comparison result, and a second analysis result is output, including:

[0124] S221: record the unconventional genes as a set G, including genes from G1 to GN, and establish a reference genome set R for each gene, including reference genomes from R1 to RN, and establish a corresponding reference genome index;

[0125] S222: For gene G1 and its reference genome R1, extract the sequencing fragment sequences aligned to G1 and its highly homologous sequence regions according to the sequence alignment results to form set S1;

[0126] S223: Align the sequencing fragment sequences in set S1 to the reference genome R1;

[0127] S224: extracting the reference genome R1 of gene G1 and the reference genome set P of highly homologous sequences, including P1 to PN, and comparing R1 with the sequences in the set P to determine the position set B of the differential base sequences, including B1 to BN, wherein for each position Bi, the corresponding base information set BNi and the reference genome number set C are recorded;

[0128] S225: According to the results of steps S223 and S224, the sequences aligned to the reference genome R1 are numbered and marked, and all positions of set B are traversed;

[0129] S226: Haplotype marking of the aligned sequences. If all positions of set B are marked as R1, then it is recorded as R1 haplotype; if some positions are marked as R1 and some are marked as P1 to PN, then it is recorded as other haplotype type set O;

[0130] S227: Perform cluster analysis on sequences of all haplotype types, record the number sets of different haplotypes and the corresponding average number of sequences, where:

[0131] For the haplotype set O, if there is one or multiple discontinuous positions Bi marked as non-R1, the haplotype is considered to be R1, indicating the presence of point mutations or insertions and deletions. If there are multiple consecutive positions Bi marked as non-R1, it is considered that the haplotype has undergone gene fusion or structural variation.

[0132] For the R1 haplotype, when the number of the R1 haplotype number set is greater than 2, it is considered that the gene G1 has a copy number duplication; when the number of the R1 haplotype number set is less than or equal to 1, it is considered that the gene G1 has a copy number deletion; when the value of the average sequence number DN corresponding to the R1 haplotype number is 1.5 to 2.5 times the value of the other number D, it is considered that there are two identical copies of the haplotype number, and the copy number variation determination result is updated accordingly;

[0133] S228: For genes G2 to GN, perform the second variation analysis in the same manner as S222 to S227.

[0134] Step S300: Summarize the first analysis result and the second analysis result of S200 and output the gene mutation analysis result.

[0135] Further, the gene mutation analysis results include at least one of single nucleotide polymorphisms, small-scale insertions and deletions, short tandem repeats, structural variations and complex genomic rearrangements as defined above.

[0136] In one embodiment, a method for detecting multiple mutation types of multiple disease-related genes comprises the following steps:

[0137] (1) Collect peripheral blood samples from the subjects to be screened and extract genomic DNA;

[0138] (2) DNA fragmentation is performed by the transposase method, and the sequencing adapter sequence is added to the core sequence at the end of the transposon using the transposition principle of the transposase. When constructing the library, only one simple enzymatic reaction is required to introduce the sequencing adapter to complete the pre-capture library construction;

[0139] (3) performing fragment sorting on the pre-capture library, removing the library with fragment length less than 5 kb as much as possible, and obtaining the screened pre-capture library;

[0140] (4) adding a customized biotin-labeled probe to the pre-capture library, hybridizing and incubating, then capturing the target fragment using streptavidin magnetic beads, and then amplifying and enriching the post-capture library using PCR primers to obtain the post-capture library;

[0141] (5) The captured library is subjected to damage repair, end repair, third-generation sequencing adapter ligation, and magnetic bead purification to complete the construction of the third-generation sequencing library;

[0142] (6) Perform sequencing on the machine according to the operating procedures of the high-precision and long-length third-generation sequencing platform;

[0143] (7) Remove sequence tags from the offline data, including the third-generation sequencing library tag, post-capture library tag, sample marker tag, and transposon tag. After completion, split the original offline data file into sequence data files (fastq format) of each sample;

[0144] (8) Align the split sequence data files to the reference genome and create an index;

[0145] (9) Based on the alignment results, analyze the variation information of point mutations and insertion / deletion, and simultaneously analyze structural variations such as copy number variation;

[0146] (10) Based on the information of heterozygous SNPs, the conventional gene sequence of the targeted amplification region is assembled to generate haplotype typing results;

[0147] (11) For genes with highly homologous sequences (e.g., CYP21A2, SMN1, etc.), the haplotypes of functional genes and highly homologous genes are distinguished based on the differential sequences between them;

[0148] (12) Based on the haplotype typing results, analyze the point mutations, insertions and deletions, and copy number variations of genes with highly homologous sequences (such as CYP21A2 and SMN1), and identify fusion genes and structural variations;

[0149] (13) Summarize the variation information and output the analysis results.

[0150] Among them, specific methods for distinguishing the haplotypes of functional genes and highly homologous genes include:

[0151] 1) For each gene with highly homologous sequences, record it as a set G (G1…GN) and establish a reference genome set R (R1…RN), and establish a reference genome index;

[0152] 2) For a gene G1 with highly homologous sequences and its reference genome R1, based on the sequence alignment results obtained in step S9, a sequence set S1 of sequencing fragments aligned to the gene and its highly homologous sequence regions is extracted;

[0153] 3) Aligning the set S1 obtained in step 2) to the reference genome R1 corresponding to G1;

[0154] 4) For gene G1, extract the reference genome set P (P1...PN) of its corresponding highly homologous sequences, compare R1 with all sequences in set P, obtain the position set B (B1...BN) of the differential base sequences between R1 and set P, and for position B1, record the base information set BN (BN1-1..BN1-N) corresponding to B1, and the reference genome number set C (such as R1, P1, P2...PN, etc.) corresponding to set BN, and complete the recording of all base information sets in set B and the corresponding reference genome numbers;

[0155] 5) According to the result of step 3), for the sequence aligned to the reference genome R1, based on the set B recorded in S11-4 and the corresponding base set BN and the corresponding reference genome number C, mark the reference genome number of the sequence aligned in step S11-3 respectively while traversing all positions of set B;

[0156] 6) According to the result of step 5), when all positions of set B on the aligned sequence are marked as reference genome R1, the sequence is recorded as R1 haplotype; when it is marked as reference genome P1, the sequence is recorded as P1 haplotype; when it is marked as reference genome PN, the sequence is recorded as PN haplotype; and so on to complete the haplotype labeling of all aligned sequences; when there is an aligned sequence, some positions of set B are marked as R1, and some are compared as P1..PN, it is recorded as other haplotype type sets O (O1...ON);

[0157] 7) Perform cluster analysis on the sequences of all haplotype types according to step 6). For all sequences of R1 haplotype, when two or more haplotypes of different sequences are clustered, record the haplotype number set as R1-Hap (Hap1..HapN) and the corresponding average sequence number set D (D1...DN). When only one haplotype of sequence is clustered, record the haplotype number as R1-Hap1. Similarly, complete the clustering of other haplotype types (P1...PN and O1...ON), and record the haplotype number set and the corresponding average sequence number set.

[0158] Furthermore, specific methods for analyzing point mutations, indels, copy number variations, and identifying fusion genes and structural variations include:

[0159] 8) For the haplotype number set obtained in step 7), if there is a haplotype type set O and only one or multiple discontinuous positions of set B are marked as non-R1, it is considered that the haplotype type is still R1 and there is a point mutation or insertion and deletion;

[0160] 9) For the haplotype number set obtained in step 7), if there is a haplotype type set O and multiple consecutive positions of set B are marked as non-R1, it is considered that gene fusion or structural variation has occurred in the haplotype type;

[0161] 10) For the haplotype number sets obtained in step 7), if the number of haplotype number sets of R1 is greater than 2, it is considered that the gene G1 has a copy number duplication; if the number of haplotype number sets is less than or equal to 1, it is considered that the gene has a copy number deletion. When the value of the average sequence number DN corresponding to a haplotype number of R1 is 1.5-2.5 times the value of D of other numbers, it is considered that there are two identical copies of the haplotype number, and the above copy number variation result is updated. For example, when the number of haplotype number sets of R1 is 2, at this time, due to the existence of two identical copies, the actual copy number of gene G1 is 3, which is a copy number duplication; when the number of haplotype number sets of R1 is 1, at this time, due to the existence of two identical copies, the actual copy number of gene G1 is 2, which is a normal copy number result.

[0162] Optionally, the method for extracting genomic DNA may be compatible with the magnetic bead method, column method for extracting DNA, and automated method for extracting DNA.

[0163] Optionally, whether to perform pre-capture library amplification can be selected according to the experimental design. If pre-capture library amplification is not performed, the amount of DNA input can be increased, and the sequencing adapter sequence and the sample tag sequence can be introduced simultaneously using a transposase with a complete sequencing adapter and tag sequence. Alternatively, the universal sequencing adapter sequence can be introduced using a transposase first, and then the sequencing adapter and sample tag sequence can be introduced by pre-capture library PCR amplification using primers with sample tags.

[0164] Optionally, the method for screening library fragments before capture can adopt traditional manual gel excision and recovery, or the currently widely used magnetic bead method for fragment sorting, or the use of a fully automatic nucleic acid electrophoresis and fragment recovery system for separation and recovery.

[0165] Optionally, the high-precision and long-length third-generation sequencing platform includes a high-base quality single-molecule real-time sequencing technology platform or a high-base quality single-molecule nanopore sequencing technology platform.

[0166] Optionally, there are genes with highly homologous sequences (eg, CYP21A2, SMN1, etc.), including genes with genome-wide similarities between gene sequences greater than or equal to 90%.

[0167] In another aspect of the present application, a device for detecting a single gene mutation of a chromosome is provided.

[0168] refer to Figure 2 , a detection device according to an embodiment of the present application comprises:

[0169] The alignment module is used to align the third-generation sequencing data to be analyzed with the reference genome;

[0170] An analysis module is used to compare the sequence reads of the third-generation long-read sequencing with the reference genome, align a portion of the sequence reads to the conventional gene region to obtain a first comparison result, perform a first variation analysis based on the first comparison result, and output a first analysis result;

[0171] Performing haplotype typing on the unconventional gene and comparing it with the remaining sequence reads to obtain a second comparison result, performing a second variation analysis based on the second comparison result, and outputting a second analysis result;

[0172] An output module, used to summarize the first analysis result and the second analysis result, and output the gene mutation analysis result;

[0173] Among them, the conventional gene refers to a gene without a highly homologous sequence, the unconventional gene refers to a gene with a highly homologous sequence, and the gene with a highly homologous sequence means that the gene has a homologous sequence with a similar sequence structure within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%;

[0174] The first variation analysis and the second variation analysis each independently include at least one of single nucleotide polymorphisms, small-scale insertions and deletions, short tandem repeats, structural variations, and complex genomic rearrangements.

[0175] In another aspect of the present application, a computer device is provided, including a memory and a processor, wherein the memory stores a computer program, and wherein the processor implements the steps of the above detection method when executing the computer program.

[0176] In another aspect of the present application, a computer-readable storage medium is provided, on which a computer program is stored, characterized in that when the computer program is executed by a processor, the steps of the above detection method are implemented.

[0177] In another aspect of the present application, a computer program product is provided, including a computer program, characterized in that the computer program implements the steps of the above detection method when executed by a processor.

[0178] The following are some specific embodiments.

[0179] For experimental parameters not specified in the following specific embodiments, reference is made to the instructions given in the present application document, and reference may also be made to experimental manuals in the art or other experimental methods known in the art, or to experimental conditions recommended by manufacturers.

[0180] The raw materials and reagents involved in the following specific examples can be obtained from commercial sources, or can be prepared by those skilled in the art according to known methods.

[0181] Example 1

[0182] 1. Nucleic acid shearing

[0183] By gradient testing the reaction system volume (100 μL / 50 μL), transposase interruption time (3 min / 5 min / 10 min) and transposase dosage (1 μL / 2 μL / 3 μL / 4 μL), the test results are shown in Table 1.

[0184] Table 1

[0185]

[0186] According to the results in Table 1, it can be found that the reaction system with a reaction system of 50 μL, a disruption time of 10 min, and a transposase dosage of 3 μL can obtain the most ideal fragment size and fragment distribution.

[0187] 2. Pre-capture library fragment screening

[0188] Magnetic bead method was used for fragment sorting. 2500 ng of the pre-capture library was taken and supplemented with water to 50 μL, 3.1× 35% (v / v) AMPure PB magnetic beads were added to it, and incubated at room temperature for 20 minutes. The supernatant was removed, and then rinsed and eluted. The sorting results are shown in Table 2.

[0189] Table 2

[0190]

[0191] According to the results in Table 2, it can be found that after magnetic bead fragment screening, the proportion of 5kb-15kb fragments was effectively increased.

[0192] 3. Clinical sample testing

[0193] 3.1 Library construction before capture

[0194] (1) Tn5 transposase labeling

[0195] 1) Prepare the reaction system shown in Table 3 on ice, flick or pipette slowly to mix, and centrifuge briefly.

[0196] Table 3

[0197] Reagents Volume (μL) 1 μg DNA X Nuclease-free water 37-X Labeling buffer 10 Labeling enzyme 3 Total volume 50

[0198] 2) Place the PCR tube in a PCR instrument and perform the reaction according to the conditions in Table 4.

[0199] Table 4

[0200] temperature Time (heat cover 105℃) 55℃ 10min 4℃ Keep

[0201] (2) Transposase release

[0202] 1) After the reaction is completed, add 10 μL of stop buffer to the reaction system immediately, shake and mix, and centrifuge instantly.

[0203] 2) Place the PCR tube in a PCR instrument and perform the reaction according to the conditions in Table 5.

[0204] Table 5

[0205] temperature Time (heat cover 105℃) 55℃ 5min 4℃ Keep

[0206] (3) Purification

[0207] 1) Add 0.7× purified magnetic beads (XP), i.e. 42 μL, to the above labeled product. Mix by flicking gently and react at room temperature for 10 minutes.

[0208] 2) Insert the PCR tube into the tube hole of the magnetic rack. After the magnetic beads are completely adsorbed and the solution becomes clear, aspirate the solution, being careful not to aspirate the magnetic beads (about 5 μL of solution can be left), and leave the PCR tube on the magnetic rack.

[0209] 3) Pipette 200 μL of 80% ethanol into the PCR tube and let it stand for 30 seconds. Aspirate the solution, being careful not to absorb the magnetic beads. 80% ethanol should be prepared on the same day.

[0210] 4) Repeat the previous step.

[0211] 5) Remove the PCR tube and centrifuge for 5 seconds. Insert the PCR tube into the tube hole of the magnetic rack again. After the magnetic beads are completely adsorbed, use a pipette to remove the residual solution. Be careful not to leave any residue on the tube wall. Open the PCR tube cap and dry it. Be careful not to crack the magnetic beads.

[0212] 6) Pipette 24 μL of nuclease-free water into the PCR tube, flick to mix, and react at room temperature for 5 minutes.

[0213] 7) Centrifuge briefly and insert the PCR tube into the tube hole of the magnetic rack. After the magnetic beads are completely adsorbed and the solution becomes clear, use a pipette to transfer 22 μL into a new PCR tube with the corresponding number. Be careful not to absorb the magnetic beads.

[0214] (4) PCR amplification

[0215] 1) Prepare the reaction system shown in Table 6 on ice, mix by flicking or pipetting with a wide-mouthed pipette, and centrifuge briefly.

[0216] Table 6

[0217] Components Volume (μL) Labeling and purification of products 22 2×PCR Mix 25 Specific primer N 3 Total volume 50

[0218] 2) Place the PCR tube on a PCR instrument and perform the reaction according to the reaction conditions shown in Table 7.

[0219] Table 7

[0220]

[0221]

[0222] (5) PCR product purification

[0223] 1) Add 0.8× purified magnetic beads (XP), i.e. 40 μL, to the PCR product. Mix by flicking gently and react at room temperature for 10 minutes.

[0224] 2) Insert the PCR tube into the tube hole of the magnetic rack. After the magnetic beads are completely adsorbed and the solution becomes clear, aspirate the solution, being careful not to aspirate the magnetic beads (about 5 μL of solution can be left), and leave the PCR tube on the magnetic rack.

[0225] 3) Pipette 200 μL of 80% ethanol into the PCR tube and let it stand for 30 seconds. Aspirate the solution, being careful not to absorb the magnetic beads. 80% ethanol should be prepared on the same day.

[0226] 4) Repeat the previous step.

[0227] 5) Remove the PCR tube and centrifuge for 5 seconds. Insert the PCR tube into the tube hole of the magnetic rack again. After the magnetic beads are completely adsorbed, use a pipette to remove the residual solution. Be careful not to leave any residue on the tube wall. Open the PCR tube cap and let it dry. Be careful not to overdry it.

[0228] 6) Pipette 52 μL of nuclease-free water into the PCR tube, flick to mix, and react at room temperature for 5 minutes.

[0229] 7) Centrifuge briefly and insert the PCR tube into the tube hole of the magnetic rack. After the magnetic beads are completely adsorbed and the solution becomes clear, use a pipette to transfer 50 μL into a new PCR tube with the corresponding number. Be careful not to absorb the magnetic beads.

[0230] 8) Take 1 μL and measure the concentration.

[0231] 3.2 Library fragment screening before capture

[0232] (1) Use elution buffer to dilute the DNA screening magnetic beads to 35% (v / v) screening magnetic beads for later use (the appropriate amount can be prepared according to the actual number of samples). The diluted magnetic beads can be stored in a 4°C refrigerator for 1 month.

[0233] (2) Take 2500 ng of the purified product from the previous step, add nuclease-free water to make up the volume to 50 μL, and add 155 μL of 35% screening magnetic beads.

[0234] (3) Gently flick and invert to mix, centrifuge at low speed for 1 second, and incubate at room temperature for 20 minutes.

[0235] (4) Place the PCR tube on a magnetic rack and let it stand for 2 minutes until the liquid becomes clear. Use a pipette to carefully aspirate and discard the supernatant.

[0236] (5) Keep the PCR tube on the magnetic rack and add 200 μL of freshly prepared 80% ethanol to rinse the magnetic beads and tube walls. After standing for 30 seconds, carefully aspirate and discard the supernatant.

[0237] (6) Repeat the previous step.

[0238] (7) Remove the PCR tube from the magnetic rack and place it in a centrifuge with the magnetic beads facing outward. Centrifuge at low speed for 1 second and then place it back on the magnetic rack. After standing for 5 seconds, aspirate and discard the supernatant and let it dry slightly.

[0239] (8) Remove the PCR tube from the magnetic rack, add 32 μL of nuclease-free water, and use a wide-mouth pipette to slowly pipette 10 times or flick until completely mixed.

[0240] (9) Incubate at room temperature for 5 minutes.

[0241] (10) Centrifuge briefly. Place the PCR tube on a magnetic rack and let it stand for 2 minutes until the liquid becomes clear. Slowly transfer 30 μL of the supernatant to a new PCR tube to ensure that there are no magnetic beads left in the supernatant. Take 1 μL and measure the concentration.

[0242] 3.3 Hybridization and capture of target nucleic acid fragments

[0243] (1) Magnetic bead concentration and probe hybridization

[0244] 1) Take 1000 ng (single hybrid) pre-capture library from each sample and add it to a PCR tube, and fill it up to 30 μL with nuclease-free water.

[0245] 2) Add 1× purified magnetic beads (XP), i.e. 30 μL, flick to mix, and incubate at room temperature for 10 min.

[0246] 3) Place the PCR tube on a magnetic stand and let it stand for 2 minutes until the liquid becomes clear. Use a pipette to carefully aspirate and discard the supernatant.

[0247] 4) Keep the PCR tube on the magnetic rack, add 200 μL of freshly prepared 80% ethanol to rinse the magnetic beads and the tube wall, let it stand for 30 seconds, then carefully aspirate and discard the supernatant.

[0248] 5) Repeat the previous step.

[0249] 6) Remove the PCR tube from the magnetic rack and place it on the centrifuge with the magnetic beads facing outward. Centrifuge at low speed for 1 second, then put it back on the magnetic rack. After standing for 5 seconds, aspirate and discard the supernatant, dry it, and ensure that there is no ethanol residue.

[0250] 7) Remove the PCR tube from the magnetic stand, add 28 μL of hybridization reaction solution, and slowly pipette 10 times or flick until completely mixed. The hybridization reaction solution is prepared as shown in Table 8.

[0251] Table 8

[0252] Components Volume (μL) Hybridization buffer 13 Blocking Buffer 1 5 Universal Blocking Buffer (Illumina Nextera) 2 Blocking Buffer 3 5 Nuclease-free water 3 Total volume 28

[0253] 8) Incubate at room temperature for 5 min.

[0254] 9) Pipette 28 μL of the eluted supernatant into a new PCR tube, and then add 2 μL of the probe.

[0255] 10) Place the PCR tube in a PCR instrument and perform the reaction according to the reaction conditions in Table 9.

[0256] Table 9

[0257] temperature time Heating cover 85℃ start 80℃ 5min 50℃ 12h~18h

[0258] (2) Experimental preparation before capture

[0259] 1) Take the capture magnetic beads out of the 4°C refrigerator in advance, mix thoroughly and equilibrate at room temperature for 30 minutes;

[0260] 2) Prepare 80% ethanol with anhydrous ethanol and nuclease-free water in advance, store it at room temperature, and use it in the purification step;

[0261] 3) Take out the washing buffer 2 from the auxiliary box 2. If there is precipitation, heat the washing buffer 2 in a 37°C water bath and use it after the precipitation is completely dissolved;

[0262] 4) Take out the washing buffer solution 3 from the auxiliary box 2 and preheat it in a water bath at 50°C;

[0263] 5) Take 50 μL of capture magnetic beads and add them to a new PCR tube. Place it on a magnetic rack for 1 min. Wait for the solution to become clear and discard the supernatant.

[0264] 6) Remove the PCR tube from the magnetic stand, add 180 μL of washing buffer 1 in auxiliary box 2, pipette or vortex to mix, and resuspend the magnetic beads;

[0265] 7) After instant centrifugation, place the PCR tube on a magnetic rack for 1 minute, wait for the solution to become clear, and discard the supernatant;

[0266] 8) Repeat steps 2.6-2.7 twice, washing the magnetic beads three times with washing buffer 1;

[0267] 9) Remove the PCR tube from the magnetic stand, add 180 μL of Wash Buffer 1, pipette or vortex to mix, and proceed to the next step immediately.

[0268] (3) Capture of target DNA

[0269] 1) Keep the hybridization product of STEP 1 on the PCR instrument, add 180 μL of capture magnetic beads prepared in the previous step to the hybridization product, and mix by pipetting;

[0270] 2) Cover the tube cap, remove the PCR tube from the PCR instrument, place it on a silent mixer, rotate at no more than 10 rpm, and combine at room temperature for 30 minutes;

[0271] 3) Remove the PCR tube, centrifuge it instantly, place it on a magnetic rack for 2 minutes, and discard the supernatant after the solution becomes clear;

[0272] 4) Remove the PCR tube from the magnetic stand, add 150 μL of wash buffer 2 to the PCR tube, gently pipette and mix to resuspend the magnetic beads, replace the tube cap, and then place it on a silent mixer for washing at room temperature for 15 minutes, with a speed not exceeding 10 rpm;

[0273] 5) Remove the PCR tube, centrifuge it instantly, place it on a magnetic stand for 2 minutes, and discard the supernatant after the solution becomes clear;

[0274] 6) Remove the PCR tube from the magnetic rack, add 150 μL of 50°C preheated washing buffer 3, gently pipette to mix, centrifuge briefly, place on a constant temperature oscillating mixer or metal bath, and incubate at 50°C for 10 min;

[0275] 7) Remove the PCR tube, centrifuge it instantly, place it on a magnetic stand for 2 minutes, and discard the supernatant after the solution becomes clear;

[0276] 8) Repeat steps 3.6-3.7 three times, washing the magnetic beads four times with washing buffer 3;

[0277] 9) Keep the PCR tube on the magnetic rack, add 200 μL 80% ethanol to the PCR tube, let it stand for 30 seconds, then completely discard the ethanol solution (you can use a 10 μL pipette to discard the residual ethanol), and dry the magnetic beads at room temperature to completely evaporate the residual ethanol;

[0278] 10) Add 23 μL of nuclease-free water to the PCR tube, remove the PCR tube from the magnetic stand, pipette to resuspend and mix the magnetic beads, and proceed to the next amplification reaction.

[0279] (4) Post-capture PCR amplification

[0280] 1) Prepare the reaction system according to Table 10.

[0281] Table 10

[0282] Components Volume (μL) Post-capture magnetic bead purification product 23 2×PCR Mix 25 Post-capture primer mix (illumina) 2 Total volume 50

[0283] 2) Place the PCR tube on the PCR instrument and set the reaction conditions according to Table 11.

[0284] Table 11

[0285]

[0286] (5) Purification after amplification

[0287] 1) Add 0.8× purified magnetic beads (XP), i.e. 40 μL, to the PCR product. Mix by flicking gently and react at room temperature for 10 minutes.

[0288] 2) Insert the PCR tube into the tube hole of the magnetic rack. After the magnetic beads are completely adsorbed and the solution becomes clear, aspirate the solution, being careful not to aspirate the magnetic beads (about 5 μL of solution can be left), and leave the PCR tube on the magnetic rack.

[0289] 3) Pipette 200 μL of 80% ethanol into the PCR tube and let it stand for 30 seconds. Aspirate the solution, being careful not to absorb the magnetic beads. 80% ethanol should be prepared on the same day.

[0290] 4) Repeat the previous step.

[0291] 5) Remove the PCR tube and centrifuge for 5 seconds. Insert the PCR tube into the tube hole of the magnetic rack again. After the magnetic beads are completely adsorbed, use a pipette to remove the residual solution. Be careful not to leave any residue on the tube wall. Open the PCR tube cap and let it dry.

[0292] 6) Pipette 32 μL of nuclease-free water into the PCR tube, flick to mix, and react at room temperature for 5 minutes.

[0293] 7) Insert the PCR tube into the tube hole of the magnetic stand. After the magnetic beads are completely adsorbed and the solution becomes clear, use a pipette to transfer 30 μL into a new PCR tube with the corresponding number. Be careful not to absorb the magnetic beads.

[0294] 8) Take 1 μL of the captured product and measure the concentration. The concentration should be > 5 ng / μL.

[0295] 3.4 Construction of third-generation sequencing library

[0296] The third-generation sequencing library was constructed according to the standard operating procedures for library construction of the high-precision and long-length third-generation sequencing platform.

[0297] 3.5 Data Analysis

[0298] (1) Sequence tag removal and sample splitting

[0299] The sequence tags of the offline data are removed, including the third-generation sequencing library tags, post-capture library tags, sample marker tags, and transposon tags. After completion, the original offline data files are split into sequence data files of each sample (fastq format).

[0300] (2) Sequence alignment

[0301] Align the split sequence data files to the reference genome (hg19 / hg38) and create an index;

[0302] (3) Variation analysis of conventional genes

[0303] 1) Based on the comparison results, analyze the variation information of point mutations, insertions and deletions, and short tandem duplications in conventional gene regions (excluding genes with high homology);

[0304] 2) Based on the analysis results of the previous step, analyze structural variations such as copy number variation.

[0305] (4) Haplotype typing of conventional genes

[0306] Based on the information of heterozygous SNPs, the conventional gene sequences of the targeted amplification region are assembled to generate haplotype typing results.

[0307] (5) Haplotype typing of highly homologous genes

[0308] For genes with highly homologous sequences (e.g., CYP21A2, SMN1, etc.), sequence assembly was performed based on the differential base sequences between the functional gene and the highly homologous gene, thereby distinguishing the haplotypes of the functional gene and the highly homologous gene;

[0309] (6) Variation analysis of highly homologous genes

[0310] 1) Based on the haplotype results obtained in the previous step, analyze the point mutations, indels, and copy number variation results of genes with highly homologous sequences (such as CYP21A2, SMN1, etc.);

[0311] 2) Based on the haplotype results, functional genes and blocks of highly homologous sequences are identified. When a block fusion occurs in a certain haplotype, the fusion gene is identified and the structural variation results are confirmed.

[0312] (7) Information aggregation and result output

[0313] The mutation information is summarized and the analysis results are output. The analysis results are shown in Table 12.

[0314] Table 12

[0315]

[0316] The detailed analysis results of each sample in Table 11 are as follows:

[0317] 1) Sample YYR

[0318] IGV map Figure 3 , it can be seen intuitively that there is 1 SMN1 copy and 2 SMN2 copies, and the SMN1:SMN2 coverage depth ratio is 1:2. The mutation detection result is SMN1 heterozygous deletion.

[0319] 2) Sample LSQ

[0320] IGV map Figure 4 It can be seen intuitively that CNV has duplication, and the duplication position is GRCh38 chrX:154877538-155647877. The mutation detection result is inversion of intron 22 of F8 gene.

[0321] 3) Sample YMX

[0322] IGV map Figure 5 , it can be seen intuitively that genes HBA1 and HBA2 have only one copy each, and there are reads across the deletion breakpoint that support the SEA deletion, and the breakpoint position is chr16:165396-186025 (GRCh38). The mutation detection result is αα / --SEA.

[0323] 4) Sample SYK

[0324] IGV map Figure 6 It can be seen intuitively that a breakpoint appears at the chromosome position chrX:32179700-32240818 (GRCh37), which is judged to be a tandem duplication of DMD exon 44 according to the alignment direction.

[0325] The mutation detection result was a duplication of exon 44 of the DMD gene.

[0326] 5) Sample ZXR

[0327] IGV map Figure 7 It can be seen intuitively that a heterozygous deletion occurs at chromosome position chrX:31685854-32006395 (GRCh37).

[0328] The mutation detection result was a heterozygous deletion of exons 45-53 of the DMD gene.

[0329] 6) Sample GAA_test7:

[0330] IGV map Figure 8 ,

[0331] Figure 8 Middle A is the point mutation NM_000152.5:c.1064T>C (GAA gene);

[0332] Figure 8 Middle B is the haplotype typing map of the upstream and downstream of the CYP21A2 gene. According to the haplotype typing results of the CYP21A2 region, it is divided into 5 haplotype results (hap1-hap5). According to the sequence alignment of the CYP21A2 region and the sequence differences of CYP21A2 and its pseudogene CYP21A1P, haplotypes hap2 / hap4 / hap5 carry CYP21A2 sequences, hap1 and hap3 carry CYP21A1P sequences, and according to the sequence differences of TNXB and its pseudogene TNXA, haplotypes hap2 and hap5 carry TNXB sequences, hap1 / hap3 / hap4 carry TNXA sequences, and haplotype hap4 has TNXB-TNXA fusion;

[0333] Figure 8 Middle C is the point mutation NM_000500.9:c.844G>T (CYP21A2);

[0334] According to the above typing results, the haplotypes carrying the mutation NM_000500.9:c.844G>T are hap4 and hap5 (hap3 is a pseudogene carrying sequence), so the mutation occurs on two copies of the CYP21A2 gene in this sample.

[0335] The mutation detection result showed a point mutation in the GAA gene, specifically NM_000152.5:c.1064T>C;

[0336] There is a point mutation in the CYP21A2 gene, specifically NM_000500.9:c.844G>T.

[0337] 7) Sample TQQ:

[0338] IGV map Fig. 9 ,

[0339] Fig. 9 A in the middle is the typing result. It can be seen intuitively that the sample carries one copy of the HBA1 gene, one copy of the HBA2 gene, and there is also a HBA2-HBA1 fusion gene (3.7kb missing gene sequence).

[0340] Fig. 9 B in the middle is the result of sequence alignment, in which the sequences of the 4.2kb duplication breakpoint and the 3.7kb deletion breakpoint were detected.

[0341] The mutation detection result was -α3.7 / αααanti4.2.

[0342] 8) Sample LH:

[0343] IGV map Fig.10 It can be seen intuitively that there is a 2.7kb insertion sequence in GRCH37 chr7:95751061.

[0344] The mutation detection result was SLC25A13 IVS16ins3kb heterozygous.

[0345] 9) Sample FMR1_test2:

[0346] IGV map Fig.11 It can be seen intuitively that the sample has 30 / 57 FMR1 CGG repeats. According to the inserted fragments of the sequence, some of the sequence inserted fragments are 30 bases, and some are more than 111 bases. According to the reference genome CGG repeat number of 20, it is judged that the sample carries 30 / 57 FMR1 CGG repeats.

[0347] Comparative Example 1

[0348] The samples of Example 1 were tested using commonly used testing techniques in the market. The specific methods and test results are as follows:

[0349] (1) Sample YYR

[0350] Detection method: MLPA targeted detection of SMN1 / SMN2;

[0351] Mutation detection results: SMN1 exons 7 and 8 are missing;

[0352] MLPA spectrum Fig.12 , MLPA probe SMN1 exon 7 and 8 heterozygous deletion. Due to the presence of highly homologous sequences, the NGS detection method cannot detect SNPs, small-scale insertions and deletions, and structural variations in this sample.

[0353] (2) Sample LSQ

[0354] Detection scheme: NGS targeted detection + PCR amplification;

[0355] Mutation detection results: There are F8 int22 inversion and CNV duplication, which is a complex genomic rearrangement;

[0356] PCR amplification detection chart Fig.13 , M: DL15000 control reagent; 1: P+Q amplification product; 2: A+B amplification product; 3: P+B amplification product; 4: A+Q amplification product.

[0357] According to the results of PCR amplification of different primer pairs, when primers PQ, PB+AQ, and AB are present, the sample is an F8Int22 inversion. Since the primers int22h2 and int22h3 are non-specific, it is impossible to distinguish whether the inversion is type I or type II.

[0358] According to the results of NGS targeted detection, the NGS method was unable to detect the inversion result, and a heterozygous duplication was found in the chromosome region chrX:154124097-154722658 (reference genome hg19), which includes exons 1-22 of the F8 gene and requires further verification by PCR.

[0359] According to Table 13, the ratio of the number of PCR amplification products of the sample F8 int22 h1-h3 to the product result of the normal female control is 1.5. According to the distribution of the gene on the X chromosome, the ratio of normal females is close to 1, and the ratio of the number of amplification products of normal males is 0.5. The LSQ of this sample is 1.5, confirming that the sample has CNV duplication.

[0360] Table 13

[0361]

[0362] For genes with high homology in the above comparison, it is necessary to combine multiple detection methods to detect multiple types of variations in sequence. For example, the NGS method mainly screens SNPs, small-scale insertions and deletions of genes, while the PCR method mainly detects or verifies structural variations, and the MLPA method is used to detect or verify copy number variations. At the same time, when complex genomic rearrangements occur, manual interpretation is required, which greatly increases the detection cost and detection cycle. Although NGS can indicate CNV duplications, the range of the duplication region is unclear. PCR primers can only verify the duplication relationship of int22h-1, int22h-2, and int22h-3, and cannot verify all the duplication regions indicated by NGS. Technically, the detection scheme that combines multiple methods still cannot achieve accurate detection and verification.

[0363] All documents mentioned in this application are cited as references in this application, just as each document is cited as reference separately. Unless they conflict with the application purpose and / or technical solution of this application, the cited documents involved in this application are cited with all contents and all purposes. When the cited documents are involved in this application, the definitions of relevant technical features, terms, nouns, phrases, etc. in the cited documents are also cited. When the cited documents are involved in this application, the examples and preferred methods of the cited relevant technical features can also be incorporated into this application as references, but are limited to the implementation of this application. It should be understood that when the cited content conflicts with the description in this application, the present application shall prevail or be modified adaptively according to the description of this application.

[0364] The technical features of the above-mentioned implementation modes and examples can be combined in any appropriate manner. To make the description concise, not all possible combinations of the technical features in the above-mentioned implementation modes and examples are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0365] The above-described embodiments only express several implementation methods of the present application, but they cannot be understood as limiting the scope of the patent application. It should be pointed out that, for those of ordinary skill in the art, without departing from the concept of the present application, several variations and improvements can also be made, which all belong to the protection scope of the present application. In addition, it should be understood that after reading the above-mentioned teaching content of the present application, those skilled in the art can make various changes or modifications to the present application, and the equivalent forms obtained also fall within the protection scope of the present application. It should also be understood that the technical solutions obtained by those skilled in the art on the basis of the technical solutions provided in the present application through logical analysis, reasoning or limited experiments are all within the protection scope of the claims attached to the present application. Therefore, the protection scope of the patent of the present application shall be based on the attached claims, and the description can be used to interpret the content of the claims.

Claims

1. A method for detecting multiple mutation types of genes related to multiple diseases, characterized in that: The steps include: S100: obtaining genomic DNA of the sample, obtaining the long-fragment DNA sequence of the target gene in the genomic DNA by a targeted capture method, and performing third-generation long-read sequencing; S200: comparing the sequence reads of the third-generation long-read sequencing with the reference genome, comparing a portion of the sequence reads to the conventional gene region to obtain a first comparison result, performing a first variation analysis based on the first comparison result, outputting a first analysis result, performing haplotype typing on the unconventional gene, obtaining a differential base sequence between the unconventional gene and a highly homologous sequence thereof, comparing the differential base sequence with the remaining portion of the sequence reads to obtain a second comparison result, performing a second variation analysis based on the second comparison result, and outputting a second analysis result; S300: Summarize the first analysis result and the second analysis result, and output a gene mutation analysis result; Among them, the conventional gene refers to a gene without a highly homologous sequence, the unconventional gene refers to a gene with a highly homologous sequence, and the gene with a highly homologous sequence means that the gene has a homologous sequence with a similar sequence structure within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%; The first analysis result and the second analysis result each independently include at least one of the following gene mutation results: single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement.

2. The detection method according to claim 1, characterized in that: The method for obtaining the long-fragment DNA sequence of the target gene in the genomic DNA comprises at least one of probe hybridization capture, PCR amplification and targeted gene editing.

3. The detection method according to claim 1, characterized in that: The sequencing platform of the third generation sequencing includes at least one of a single molecule real-time sequencing technology platform and a single molecule nanopore sequencing technology platform.

4. The detection method according to claim 1, characterized in that: The long DNA sequence satisfies at least one of the following conditions: (1) Average length > 5 kb; (2) Length ranges from 500bp to 300kb.

5. The detection method according to claim 1, characterized in that: Performing a first variation analysis according to the first comparison result includes: Analyzing first variation information of the conventional gene according to the first comparison result, the first variation information including single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat and structural variation; Furthermore, the structural variation includes copy number variation.

6. The detection method according to claim 1, characterized in that: The method further comprises: performing a first variation analysis according to the first comparison result and outputting a first analysis result. The conventional gene is subjected to haplotype typing according to the information of the heterozygous SNP in the first comparison result.

7. The detection method according to claim 1, characterized in that: Performing a second variation analysis according to the second comparison result includes: analyzing second variation information of the unconventional gene according to the second comparison result, wherein the second variation information includes at least one of single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement; Furthermore, the structural variation includes at least one of copy number variation, gene fusion, and large-segment gene conversion and inversion; Furthermore, the complex genome rearrangement refers to the occurrence of multiple types of structural variations within the same gene region.

8. The detection method according to claim 1, characterized in that: Performing haplotype typing on the unconventional gene to obtain a differential base sequence between the unconventional gene and a highly homologous sequence therein, comparing the differential base sequence with the remaining sequence read to obtain a second comparison result, performing a second variation analysis based on the second comparison result, and outputting a second analysis result, including: S221: Record the unconventional genes as a set G, including genes G1 to GN, and establish a reference genome set R for each gene, including reference genomes R1 to RN, and establish a corresponding reference genome index; S222: For gene G1 and its reference genome R1, extract the sequencing fragment sequences aligned to G1 and its highly homologous sequence regions according to the sequence alignment results to form set S1; S223: Align the sequencing fragment sequences in set S1 to the reference genome R1; S224: extract the reference genome R1 of gene G1 and the reference genome set P of highly homologous sequences, including P1 to PN, and compare R1 with the sequences in the set P to determine the position set B of the differential base sequences, including B1 to BN, wherein for each position Bi, record its corresponding base information set BNi and reference genome number set C, and complete the recording of all base information sets in the set B and the corresponding reference genome numbers; S225: According to the results of steps S223 and S224, the sequences aligned to the reference genome R1 are numbered and marked, and all positions of set B are traversed; S226: Haplotype marking of the aligned sequences. If all positions of set B are marked as R1, then it is recorded as R1 haplotype; if some positions are marked as R1 and some are marked as P1 to PN, then it is recorded as other haplotype type set O; S227: Perform cluster analysis on sequences of all haplotype types, record the number sets of different haplotypes and the corresponding average number of sequences, where: For the haplotype set O, if there is one or multiple discontinuous positions Bi marked as non-R1, the haplotype is considered to be R1, indicating the presence of point mutations or insertions and deletions. If there are multiple consecutive positions Bi marked as non-R1, it is considered that the haplotype has undergone gene fusion or structural variation. For the R1 haplotype, when the number of the R1 haplotype number set is greater than 2, it is considered that the gene G1 has a copy number duplication; when the number of the R1 haplotype number set is less than or equal to 1, it is considered that the gene G1 has a copy number deletion; when the value of the average sequence number DN corresponding to the R1 haplotype number is 1.5 to 2.5 times the value of the other number D, it is considered that there are two identical copies of the haplotype number, and the copy number variation determination result is updated accordingly; S228: For genes G2 to GN, perform the second variation analysis in the same manner as S222 to S227.

9. A detection device, characterized in that: The detection device comprises: The alignment module is used to align the sequence reads of the third-generation long-read sequencing with the reference genome; An analysis module is used to compare the sequence reads of the third-generation long-read sequencing with the reference genome, align a portion of the sequence reads to the conventional gene region to obtain a first comparison result, perform a first variation analysis based on the first comparison result, output the first analysis result, perform haplotype typing on the unconventional gene, obtain a differential base sequence between the unconventional gene and its highly homologous sequence, compare the differential base sequence with the remaining portion of the sequence reads to obtain a second comparison result, perform a second variation analysis based on the second comparison result, and output the second analysis result; An output module, used to summarize the first analysis result and the second analysis result, and output a gene mutation analysis result; Among them, the conventional gene refers to a gene without a highly homologous sequence, the unconventional gene refers to a gene with a highly homologous sequence, and the gene with a highly homologous sequence means that the gene has a homologous sequence with a similar sequence structure within the genome, and the similarity between the gene sequence and the homologous sequence is ≥90%; The first analysis result and the second analysis result each independently include at least one of the following gene mutation results: single nucleotide polymorphism, small-scale insertion and deletion, short tandem repeat, structural variation and complex genome rearrangement.

10. A computer device comprising a memory and a processor, wherein the memory stores a computer program, characterized in that: When the processor executes the computer program, the steps of the detection method according to any one of claims 1 to 9 are implemented.

11. A computer-readable storage medium having a computer program stored thereon, characterized in that: When the computer program is executed by a processor, the steps of the detection method according to any one of claims 1 to 9 are implemented.

12. A computer program product, comprising a computer program, characterized in that When the computer program is executed by a processor, the steps of the detection method according to any one of claims 1 to 9 are implemented.

Citation Information

Cited By

  • Variation detection method, system and equipment based on group-scale third-generation sequencing data and medium

    CN119763663A

  • Gene variation detection method and device, electronic equipment and storage medium

    CN120340601A

  • Method, computing device and program product for determining copy number of target member genes in homologous gene family

    CN121963883A